Journal of antivirals & antiretrovirals is one of the best open access journals in the field of virology. The open access policy of the journals mainly aims at increasing the visibility and accessibility of the published quality work and thus providing the desirable researches to the readers.
HIV Therapeutics mainly involves the discovery and development of antiviral drugs, compounds, and clinical methods to prevent HIV. Importantly, it provides the opportunity to study different pathways to stop, eradicate virus from the system and also spreads information to the researchers, clinicians, and others working in the field of antiviral drugs and therapies. JAA is an internationally recognized journal for scientists involved in basic, applied, and clinical aspects of antiviral and antiretroviral research. It is known that many viruses emerge and re-emerge threatening both animal and human populations.
OMICS Group offers an opportunity and a forum of Open Access Scholarly Published Articles (OASPA) for bringing together all the scientific communities of Open Access journal publishers. The main mission is to expose, spread the areas of Open Access (OA) journals and book publishers globally in all Fields such as environmental, Life sciences, clinical, technical, engineering models and scholarly disciplines. The goal to spread knowledge via exchanging information from subject to subject, easy access through information technologies, setting standards, Innovative models, and promoting innovation. We can ensure a prosperous and sustainable future to the benefit of our members and the scholarly communities they serve..
Omics group is now providing an opportunity to authors to share their valuable research on virology across linguistic borders in different languages such as French, German, Spanish, Chinese, Japanese, and English. By translating scientific paper into the mentioned languages we ensure an efficient exchange of knowledge and scientific experience.
Last date updated on October, 2020